Immunotherapy at ASCO25: Drug Development, Melanoma Treatment, and More

<p>Dr. Diwakar Davar and Dr. Jason Luke discuss novel agents in melanoma and other promising new data in the field of immunotherapy that were presented at the 2025 ASCO Annual Meeting.</p> <p><span style= "text-decoration: underline;"><strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal"><strong><span style= "font-family: 'Calibri',sans-serif;">Dr. Diwakar Davar:</span></strong> <span style= "font-family: 'Calibri',sans-serif;">Hello. My name is Diwakar Davar, and I am welcoming you to the <em>ASCO Daily News</em> Podcast. I'm an associate professor of medicine and the clinical director of the Melanoma and Skin Cancer Program at the University of Pittsburgh's Hillman Cancer Center. Today, I'm joined by my colleague and good friend, Dr. Jason Luke. Dr. Luke is a professor of medicine. He is also the associate director of clinical research and the director of the Phase 1 IDDC Program at the University of Pittsburgh's Hillman Cancer Center. He and I are going to be discussing some k...